26.09.2016 19:07:00

Wyeth -- Moody's affirms Pfizer's ratings; changes outlook to stable

New York, September 26, 2016 -- Moody's Investors Service ("Moody's") affirmed the ratings of Pfizer Inc. and related subsidiaries, including the A1 senior unsecured long-term rating and the Prime-1 commercial paper rating. At the same time, Moody's revised the rating outlook to stable from negative. This rating action follows the announcement that Pfizer will not pursue a split of its pharmaceutical business.

Vollständigen Artikel bei Moodys lesen